Michael R. Bishop, M.D.

Michael R. Bishop, M.D. is a prominent physician and researcher specializing in hematology, oncology, and cellular therapy at the University of Chicago. Here are some key details about Dr. Bishop:

Professional Roles

Dr. Bishop currently holds several important positions at the University of Chicago:

• Director of the David and Etta Jonas Center for Cellular Therapy
• Director of the Hematopoietic Cellular Therapy Program
• Professor of Medicine in the Division of Hematology and Oncology12

Expertise and Research

Dr. Bishop is an expert in:

• Hematopoietic stem cell transplantation (bone marrow transplantation)
• Cellular therapy
• Treatment of lymphomas and hematologic malignancies
• CAR T-cell therapy and immunotherapy2

His research focuses on developing novel clinical trials in stem cell transplantation and cellular therapy, with particular emphasis on:

• Using T cells to treat blood cancers and solid tumors
• Preventing and treating disease recurrence after stem cell transplantation
• Enhancing the immune effects of transplanted cells against cancer12

Career Highlights

• Joined the National Cancer Institute in 1999 as Clinical Head of the Stem Cell Transplantation Program
• Received tenure as Senior Investigator at NIH in 2007
• Appointed to his current roles at the University of Chicago in 2012 and 2020
• Named a Bucksbaum Institute for Clinical Excellence Master Clinician in 2013
• Consistently named one of the "Best Doctors in America" since 200112

Publications and Leadership

Dr. Bishop has made significant contributions to medical literature, including:

• Authoring over 200 peer-reviewed articles in prestigious journals
• Writing over 35 book chapters on hematologic malignancies and cellular therapy
• Serving on editorial boards of several scientific journals1

His expertise and leadership in the field have earned him recognition and influential roles in various medical societies and organizations.